In type 2 diabetes, GLP-1 RA plus SGLT2 inhibitor vs. either drug alone reduces HbA<sub>1c</sub> and SBP and may reduce body weight.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 33197349.
- Also identified by DOI 10.7326/ACPJ202011170-052.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mantsiou C, Karagiannis T, Kakotrichi P, et al. <b>Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: a systematic review and meta-analysis.</b> Diabetes Obes Metab. 2020;22:1857-68. 32476254.
Medical subject headings
- Diabetes Mellitus, Type 2
- Pharmaceutical Preparations
- Sodium-Glucose Transporter 2 Inhibitors
- Symporters